2105: Q&A with Poolbeg Pharma CEO, Jeremy Skillington
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
2105: Q&A with Poolbeg Pharma CEO, Jeremy Skillington
-
Narrated by:
-
By:
About this listen
Following on from its £4.865 million raise last week, Poolbeg #POLB has announced that it has received FDA Orphan Drug Designation for POLB 001. Chief executive Jeremy Skillington joins us to tell us what it all means.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet